Expanding the Spectrum of Pediatric NTRK -rearranged Mesenchymal Tumors

Jessica L. Davis, Christina M. Lockwood, Bradley Stohr, Carolin Boecking, Alyaa Al-Ibraheemi, Steven G. Dubois, Sara O. Vargas, Jennifer O. Black, Michael C. Cox, Mark Luquette, Brian Turpin, Sara Szabo, Theodore W. Laetsch, Catherine M. Albert, David M. Parham, Douglas S. Hawkins, Erin R. Rudzinski

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Pediatric mesenchymal tumors harboring variant NTRK fusions (ETV6-negative) are being increasingly described; however, the histologic and clinical features of these variant NTRK tumors and their relationship to classic infantile fibrosarcoma are not well characterized. A better understanding of the clinicopathologic features of these tumors is necessary, and would aid in both early diagnosis and treatment. Therefore, the aim of this study was to characterize a series of pediatric NTRK-rearranged mesenchymal tumors, including classic ETV6-NTRK3 fused tumors and tumors with variant (non-ETV6) NTRK fusions. The clinical features, morphology, immunophenotype, and genetics of 12 classic ETV6-NTRK3 fused infantile fibrosarcoma and 18 variant NTRK-rearranged mesenchymal tumors were evaluated. For both classic and variant groups, the age at diagnosis ranged from birth to 15 years (median, 4 mo) with no sex predilection; the most common sites involved were the extremities and trunk. The rate of local recurrence and metastasis were not significantly different (recurrence rate: 11% classic, 40% variant; metastatic rate: 18% classic, 25% variant). Classic and variant NTRK tumors had an overlapping spectrum of histologic features, containing haphazardly arranged primitive cells in a myxoid background and/or spindle cells in long fascicles. Both groups showed diffuse pan-TRK expression by immunohistochemistry. Otherwise, the immunoprofile was nonspecific, but similar between both groups. No statistical difference was seen in any clinicopathologic feature between the classic ETV6-NTRK3 and variant fusion cohorts. Pediatric NTRK-rearranged mesenchymal tumors with both classic and variant fusions likely represent a spectrum of disease with shared, recognizable cliniopathologic features.

Original languageEnglish (US)
Pages (from-to)435-445
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume43
Issue number4
DOIs
StatePublished - Apr 1 2019

Keywords

  • NTRK
  • TRK
  • infantile fibrosarcoma
  • pediatric
  • soft tissue sarcoma

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Expanding the Spectrum of Pediatric NTRK -rearranged Mesenchymal Tumors'. Together they form a unique fingerprint.

  • Cite this

    Davis, J. L., Lockwood, C. M., Stohr, B., Boecking, C., Al-Ibraheemi, A., Dubois, S. G., Vargas, S. O., Black, J. O., Cox, M. C., Luquette, M., Turpin, B., Szabo, S., Laetsch, T. W., Albert, C. M., Parham, D. M., Hawkins, D. S., & Rudzinski, E. R. (2019). Expanding the Spectrum of Pediatric NTRK -rearranged Mesenchymal Tumors. American Journal of Surgical Pathology, 43(4), 435-445. https://doi.org/10.1097/PAS.0000000000001203